{"pageContent": "Objective: to estimate the standard performance measures of prostate-specific antigen (PSA) screening as implemented in the existing health care system and to compare the observed results with those fom the European Randomized Screening for Prostate Cancer (ERSPC) trial.", "metaData": {"source": "Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors\nhttps://pubmed.ncbi.nlm.nih.gov/31106980/"}}